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Increased blood visfatin concentrations have been implicated in several diseases, such as type 2 diabetes mellitus, 2 osteoarthritis, 3 rheumatoid arthritis, 4 and gastric cancer.
5
Besides adult diseases, visfatin levels are implicated in fetal growth and intrauterine growth restriction (IUGR). 6, 7 Pathologic conditions in pregnancy leading to IUGR could be responsible for elevated maternal visfatin levels. 7 Furthermore, higher visfatin levels in neonates with IUGR may serve as an early prognostic marker for later development of insulin resistance or type 2 diabetes mellitus. 7 The identification of reliable risk markers able to predict the development of diseases is essential both in adults and infants/ neonates. Monitoring such markers may be used as a guide to selecting appropriate drugs as well as to predict the course/ prognosis of a disease. 8 
